Equity
DR. RIVERO paid out €361,593 in dividends. That is 92% of the 2025 profit.
DR. RIVERO paid out €361,593 in dividends. That is 92% of the 2025 profit.
The accounts state no turnover.
Debts rose by €285,561 in 2025.
Short-term debts rose from €208,214 to €598,850.
Four of the last ten came late. The 2019 accounts came in latest, 119 days after the end of the period.
Higher net result than 95% of companies in human health. The sector median is €59,541, over 21,360 companies.
In July 2024, 17,817 companies had the same profile as DR. RIVERO has now. Each dot stands for 45 companies, two years later.
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,817 companies, not a prediction for DR. RIVERO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| DR. RIVERO Genk | €3.2m | €627,550 | 56.5% | - |
| RADIOLOGIE DR. GENIETS Herzele | €3.2m | €627,420 | 81.4% | - |
| DR.DAENEN & DR.MOL Turnhout | €3.1m | €628,253 | 93.4% | - |
| DOKTER AN NOLLET Ypres | €3.2m | €605,877 | 83.6% | - |
| DOKTER MICHIEL MARCHAU EN DOKTER VéRONIQUE JACOBS Brakel | €3.1m | €570,352 | 94.5% | - |
| DR. SOPHIA STEYAERT Ghent | €2.9m | €619,502 | 96.1% | - |
| DR. DHONDT ERIK Torhout | €2.8m | €601,854 | 87.6% | - |
These companies have the same main activity as DR. RIVERO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.8m and €3.2m, founded between 2005 and 2008.
DR. RIVERO files the micro format. That format states no turnover. The gross margin rose from €12,006 in 2007 to €627,550 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.